• Pronase E Protease Mixture: Precision Protein Digestion in P

  2026-07-27

  Pronase E’s high activity and non-specific cleavage deliver robust protein sample preparation for advanced proteomic workflows. Leveraging recent insights from ferroptosis research, this article details optimized protocols, troubleshooting, and the unique advantages of APExBIO’s Pronase E for molecular biology applications.

• Phosphoenolpyruvate Restricts cGAS-STING Inflammation in Agi

  2026-07-27

  This study uncovers a conserved adaptive mechanism in which phosphoenolpyruvate (PEP), a key glycolytic metabolite, inhibits the cGAS–STING pathway to mitigate age-associated inflammation. The findings illuminate pivotal metabolic-inflammation cross-talk and suggest new avenues for targeting inflammaging and neurodegenerative diseases.

• Applied Use of (-)-Blebbistatin in Cytoskeletal Dynamics Res

  2026-07-26

  (-)-Blebbistatin, a selective non-muscle myosin II inhibitor from APExBIO, empowers precise control of actin-myosin interaction inhibition in cell mechanics and force-transduction assays. This guide delivers protocol optimizations, troubleshooting strategies, and workflow enhancements for advanced cell adhesion, migration, and mechanotransduction studies.

• Cinoxacin in Laboratory Research: Quinolone Antibiotic Proto

  2026-07-25

  Cinoxacin is a potent quinolone antibiotic, ideally suited for targeted research on Gram-negative pathogens and antibiotic resistance. This guide translates mechanistic insights and validated workflows into practical, reproducible protocols—including troubleshooting for assay optimization and cross-study comparability.

• Bafilomycin C1: Advanced V-ATPase Inhibition for Cell Assays

  2026-07-24

  Bafilomycin C1 delivers unparalleled control over lysosomal pH, empowering high-content autophagy and toxicity assays in iPSC-derived and cancer models. This guide unpacks experimental workflows, troubleshooting, and deep-learning innovations, ensuring researchers harness APExBIO’s gold-standard inhibitor for robust, reproducible results.

• 5-Ethynyl-2'-deoxyuridine (5-EdU): Precision Tools for Hypox

  2026-07-24

  Discover how 5-Ethynyl-2'-deoxyuridine (5-EdU) enables next-generation cell proliferation assays, uniquely empowering hypoxia and chemoresistance research. This article delves into mechanistic insights and methodological advances for advanced tumor growth analysis.

• Chlorambucil in Translational Oncology: Mechanisms, Metrics,

  2026-07-23

  This article explores how chlorambucil, a nitrogen mustard alkylating agent, provides a unique window into the mechanistic and quantitative evaluation of cancer therapeutics. Integrating recent advances in in vitro assay design, it offers actionable guidance for translational researchers seeking to move beyond traditional viability metrics, optimize cytotoxicity protocols, and interpret DNA crosslinking effects with greater precision. The discussion is anchored in current evidence, including Schwartz’s dissertation, and positions APExBIO’s high-purity chlorambucil as a research-enabling tool.

• In Situ Tumor Cell Membrane Editing Enhances PD-L1 Blockade

  2026-07-23

  This study introduces a self-assembling peptide nanoparticle, TPM1, that targets and aggregates PD-L1 on tumor cell membranes, enhancing immune checkpoint blockade efficacy. By leveraging in situ nanofibril transformation, the approach addresses key limitations of current antibody-based immunotherapies and offers a promising strategy for sustained cancer immune modulation.

• Plk1 Phosphorylation Regulates p31comet in Mitotic Checkpoin

  2026-07-22

  This study elucidates how Polo-like kinase 1 (Plk1) regulates the function of p31comet by phosphorylation at serine 102, controlling the disassembly of mitotic checkpoint complexes (MCC) and thus the fidelity of mitotic progression. The findings clarify a key mechanism that prevents premature checkpoint inactivation during mitosis, with implications for understanding cell division and potential research applications.

• BMX Kinase–Mediated ATP6V1E1 Phosphorylation Enables Mtb Sur

  2026-07-22

  The reference study reveals that Mycobacterium tuberculosis (Mtb) manipulates host BMX kinase to phosphorylate the lysosomal V-ATPase subunit ATP6V1E1, thereby suppressing lysosomal acidification and promoting bacterial intracellular survival. These findings uncover a mechanistic axis in host-pathogen interaction, highlighting BMX kinase as a promising target for host-directed tuberculosis therapies.

• RSV NS3 Hijacks Host Kinase Signaling to Balance Pathogenici

  2026-07-21

  Zhuang et al. (2025) demonstrate that Rice stripe virus (RSV) NS3 protein exploits host kinase signaling, particularly the OsSnRK3.25-OsCBL1/3-OsRBOHF pathway, to modulate both viral pathogenicity and transmission. This mechanistic insight advances our understanding of virus-vector-plant co-survival strategies and offers translational relevance for research on host signaling manipulation.

• Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit

  2026-07-21

  The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit addresses the challenge of high-resolution separation of proteins and peptides in the 1–10 kDa range, where conventional Tris-glycine SDS-PAGE is inadequate. It is intended strictly for research workflows and is not suitable for diagnostic or clinical use.

• Lipo3K Transfection Reagent: Powering Advanced Gene Expressi

  2026-07-20

  Lipo3K Transfection Reagent streamlines high-efficiency nucleic acid delivery, even in challenging and sensitive cell lines, with minimal cytotoxicity. Its unique workflow flexibility and nuclear delivery enhancer unlock reliable results for gene expression and RNA interference research, making it a robust choice for cutting-edge experimental designs.

• Hydroxycinnamic Acids Disrupt COPII-STING Axis to Attenuate

  2026-07-20

  This study uncovers how hydroxycinnamic acids (HCAs) from traditional medicinal plants directly target the COPII cargo sorting machinery, competitively inhibiting STING trafficking and dampening cGAS-STING-driven inflammation. The findings offer a detailed mechanistic rationale for the metabolic and anti-inflammatory benefits of HCA-rich therapies and open new avenues for targeting autoinflammatory disorders.

• PD0325901 MEK Inhibitor: Applied Workflows for Cancer Resear

  2026-07-19

  Harness the power of PD0325901 for precise inhibition of the RAS/RAF/MEK/ERK pathway in oncology and stem cell models. This guide delivers actionable protocols, troubleshooting strategies, and direct translation of pioneering chromatin accessibility research into practical MEK inhibitor assay design.

15763 records 1/1051 page Next 12345 下5页 Last page